
==== Front
J Family Med Prim Care
J Family Med Prim Care
JFMPC
J Family Med Prim Care
Journal of Family Medicine and Primary Care
2249-4863
2278-7135
Wolters Kluwer - Medknow India

JFMPC-13-3398
10.4103/jfmpc.jfmpc_118_24
Original Article
Sleep quality and glycemic control in adults with type 2 diabetes mellitus
Borzouei Shiva 1
Ahmadi Asma 2
Pirdehghan Azar 3
1 Department of Endocrinology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
2 Department of Community and Preventive Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3 Department of Community and Preventive Medicine, School of Public Health and Research Center for Health Sciences, Hamadan University of Medical Sciences, Hamadan, Iran
Address for correspondence: Dr. Azar Pirdehghan, School of Public Health and Research Center for Health Sciences, Hamadan University of Medical Sciences, Hamadan, Iran. E-mail: pirdehgan93@gmail.com
8 2024
26 7 2024
13 8 33983402
23 1 2024
06 4 2024
30 4 2024
Copyright: © 2024 Journal of Family Medicine and Primary Care
2024
https://creativecommons.org/licenses/by-nc-sa/4.0/ This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
ABSTRACT

Aim:

Type 2 diabetes mellitus (T2DM) is a common disease that imposes a substantial burden on the healthcare system and patients. Lifestyle modification such as sleep hygiene plays a crucial role in glycemic control. Sleep disorders impact many aspects of health. In this study, we aimed to investigate the correlation between sleep quality and glycemic control in T2DM. Method: This cross-sectional study was performed on 163 T2DM patients, attending Shahid Beheshti Hospital in Hamadan, Iran from March 2020 to 2021. Besides recording the demographic data and HbA1c level of participants, they were asked the Pittsburgh Sleep Quality Index questionnaire for evaluating sleep quality. We employed SPSS ver. 21 for data analysis and considered 0.05 as a significant level

Results:

Among all participants, 62 (38%) were female and 30.7% were illiterate. The mean age was 56.67 ± 12.90 years, and HbA1c was 9.03 ± 1.92 mg/dL. Among sleep metrics, mean waking time was 8.74 ± 1.74 hours, and average sleep time was 12.90 ± 4.90 hours. Overall, 58.2% of the participants had poor glycemic control and 44.8% were suffering from poor sleep quality. We found that patients with poor glycemic control exhibited significantly higher levels of sleep disturbances compared to those with good glycemic control (P < 0.001).

Conclusion:

Sleep quality is associated with glycemic control in patients with T2DM. Sleep disorders are common among diabetic patients. Thus, healthcare providers need to consider sleep quality improvement in their holistic approach to diabetes management.

Blood glucose control
type 2 diabetes mellitus
sleep
==== Body
pmcIntroduction

Type 2 diabetes mellitus (T2DM) is a serious public health issue that imposes a significant economic burden on the healthcare system, patients, and their families.[12] In 2021, approximately 537 million individuals aged 20–79 years had diabetes, and this number is estimated to increase to approximately 643 million by 2030 and 783 million by 2045.[3]

A study has indicated that three out of four adults diagnosed with diabetes reside in low- and middle-income countries.[4] The Middle East and North Africa Region (MENA), which includes the Islamic Republic of Iran, shows the highest incidence of diabetes cases compared to other regions globally, and Iran ranks third in regard to diabetes incidence within the region.[5] In 2020, approximately 9.4% of adults in Iran were estimated to have diabetes.[6] Despite substantial investments, diabetes remains a prevalent and steadily rising condition in both Iran and worldwide.[1] The microvascular and macrovascular complications of diabetes are the major cause of morbidity and mortality associated with the disease.

In addition, research findings have shown that approximately 80% of the economic burden associated with DM is attributed to the management and treatment of these complications.[78] Some studies have indicated that maintaining optimal glycemic control (HbA1c ≤ 7%) can lead to a decrease in the incidence of long-term diabetes complications and the overall burden of the disease.[7910]

Several factors have been identified as being associated with poor glycemic control. These factors include sociodemographic characteristics of the patients, duration of diabetes, adherence to lifestyle modifications and medication, and self-monitoring of glucose levels.[11] The prevalence of sleep disturbances and deprivation has been growing in recent years.[12] In addition, it is found that there is a bidirectional relationship between sleep disorders and diabetes: while diabetes and its complications lead to sleep disorders, disturbance in both sleep quality and quantity can lead to poorer diabetes control and a higher complication rate.[13]

Although the pathophysiology of this relationship is not fully understood, there are some possible explanations. Sleep deprivation causes an increase in the activity of the sympathetic nervous system, resulting in overfeeding. In addition, elevation in the levels of cortisol and ghrelin, a hormone that stimulates hunger, and reduction in leptin, a hormone that stimulates satiety, can be the result of sleep deprivation.[1415]

The Pittsburgh Sleep Quality Index (PSQI) is the most commonly used questionnaire for evaluating an individual’s sleep quality and disturbances over the past month. It consists of several components, including subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medications, and daytime dysfunction.[16] Several studies have been conducted to investigate the influence of sleep disorders on glycemic control. However, limited research has specifically examined the impact of disturbances in each subscale of the PSQI on glycemic control.

In the current study, we aimed to assess the sleep quality of adult patients with T2DM in Hamadan, Iran, and the association between sleep quality and glycemic control.

Materials and Methods

Study setting

This observational cross-sectional study was conducted at Shahid Beheshti Hospital in Hamadan, Iran from March 2020 to March 2021.

Sample size and sampling

Cochran’s formula was used to calculate the sample size:

where n is the required sample size, Z is equal to 1.96 for a 95% confidence level, e is the acceptable margin of error (0.05), and P refers to the estimated proportion of a specific disease in the population, which is usually determined from former studies (69% in this case based on a study performed by Farooque et al.).[17] The sample size required for the study, as calculated by the formula, was 163 individuals.

Data collection

The study population consisted of all adult patients with T2DM who were referred to the hospital during the study period. All diabetes patients who wanted to participate in this study were included, and those with a history of any respiratory diseases, chronic illnesses, psychiatric disorders, or use of psychiatric medications, sleeping pills, or illicit drugs were excluded from the study. The survey consisted of two parts. The first part included questions about the participants’ demographic features such as gender, age, job, level of education, weight, height, location of residence (rural or urban), HbA1c level, and duration of diabetes. In the second part, participants completed the PSQI questionnaire, which is a self-rated questionnaire that evaluates adults’ sleep quality and disturbances over the past month.

The PSQI questionnaire comprises 19 questions that are classified into seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Each component has a score ranging from 0 to 3 that is interpreted as follows: no sleep problem: score of 0, mild sleep problem: score of 1, moderate sleep problem: score of 2, and severe sleep problem: score of 3. The global PSQI score is obtained by adding up all the component scores, ranging from 0 to 21. A PSQI score of 5 or higher indicates poor sleep quality.[16]

Data analysis

We employed SPSS. 21 for performing data analysis. Mean and standard deviation (SD) were used to describe the quantitative variables, while frequency represented as a percentage (%) was used to describe the qualitative variables. For data analysis, we employed t-tests and analysis of variance, and we considered P values lower than 0.05 to be statistically significant.

Ethical issues

We obtained approval from the institute’s ethical committee [IR.UMSHA.REC.1399.428] prior to conducting the study. All participants were informed of the study’s nature and purpose and provided their consent before participating.

Results

In total, 163 participants with T2DM participated in this study; their demographic characteristics are presented in Table 1.

Table 1 Demographic characteristics of participants with type 2 diabetes mellitus (n=163)

Characteristic	Mean±SD	Range (Max–Min)	No. (%)	
Age (years)	56.7±12.9	30–81		
Height (cm)	168.9±9.2	145–185		
Weight (kg)	83.9±11.6	50–104		
Sleep hygiene (different domains)				
 BMI	26.22±1.95			
 Wake-up time	8±1.74			
 Bedtime	12±4.9			
 Sleep duration	8±5.2			
 HbA1c (%)	9.1±1.9	4–14		
 Duration of diabetes (years)	13±6.5	2–31		
Male			101 (62%)	
Female			62 (38%)	
Education				
Illiterate			50 (30.7%)	
primary school graduate			85 (52.1%)	
high school graduate			23 (14.1%)	
university-educated			5 (3.1%)	

Out of 163 participants, 95 (58.2%) had poor glycemic control (HbA1c ≥ 7%) and 68 (41.8%) had good glycemic control. Overall, 73 (44.8%) participants had poor sleep quality (global PSQI score > 5).

We found out that 28.4% of patients with good glycemic control had poor sleep quality, while this number was 55.8% among patients with poor glycemic control. Thus, patients who had poor glycemic control demonstrated a significantly greater rate of poor sleep quality compared to patients with good glycemic control (P < 0.001).

The frequency distribution of PSQI components is shown in Figure 1.

Figure 1 Distribution of sleep difficulties based on PSQI components in type 2 diabetes mellitus patients (n = 163)

Out of 95 patients who had good glycemic control, the highest frequency was related to moderate sleep disturbances (35.7%), while in patients with poor glycemic control, the highest frequency was related to severe sleep disturbances (36.7%). Overall, patients with poor glycemic control exhibited significantly higher levels of sleep disturbances compared to those with good glycemic control (P < 0.001) [Table 2].

Table 2 Relationship between glycemic control and sleep problem severity in type 2 diabetes mellitus patients (n=163)

	HbA1c	P	
	
7< HbA1c	7≥ HbA1c	
Frequency (%)	Frequency (%)	
No sleep problem	31 (32.6%)	12 (17.6%)	<0.001	
Mild sleep problem	34 (35.7%)	14 (20.5%)		
Moderate sleep problem	20 (21%)	25 (36.7%)		
Severe sleep problem	10 (10.5%)	17 (25%)		
Total	95 (100%)	68 (100%)		

There was no statistically significant correlation between sleep quality and gender, education level, wake-up time, bedtime, and sleep duration (P > 0.05).

Logistic regression analysis of the relationship between poor glycemic control and each component of the PSQI questionnaire is shown in Table 3.

Table 3 Logistic regression analysis for different domains of sleep disturbance as predictors for poor glycemic control in type 2 diabetes mellitus patients (n=163)

Variables*	Odd ratio (95% CI)	P	
Subjective sleep quality	5.67–12.8	0.005	
Sleep latency	−0.19–10.29	0.5	
Sleep duration	0.14–11.23	0.002	
Habitual sleep efficiency	5.67–15.78	0.04	
Use of sleeping medication	0.94–14.82	0.07	
Daytime dysfunction	10.32–14.56	0.01	
• All variables were considered as binary: good and poor;	
• Poor situation for all of them considered as Referent	

Discussion

The study aimed to assess the sleep quality of adult patients with T2DM and the association between sleep quality and glycemic control in some Iranian diabetic patients.

We found that nearly 50% of diabetic patients were suffering from poor sleep quality, and patients with poor glycemic control exhibited significantly higher levels of sleep disturbances compared to those with good glycemic control.

Diabetes mellitus poses a significant challenge in today’s human society, especially in low-income countries such as those in the Middle East. It plays a crucial role in causing various issues in different organ systems.[1819] The nervous system is particularly susceptible to the direct effects of T2DM, leading to organ deficiencies due to diabetes-related neuropathy.[20] Moreover, T2DM has the potential to induce significant defects in various centers of the brain. Studies have indicated a strong correlation between uncontrolled T2DM and sleep disorders.

While abundant evidence supports the link between T2DM and sleep disorders, it is crucial to acknowledge the bidirectional nature of this relationship.[19] Notably, sleep disorders can not only be a consequence of uncontrolled T2DM but also act as a contributing factor, potentially intensifying the progression of the condition.[19] This bidirectional dynamic operates through various mechanisms, including potential effects on insulin release, thus highlighting the complexity and mutual influence between T2DM and sleep disorders.[2021] Given that T2DM is more prevalent and precedes sleep disorders, investigations typically prioritize T2DM as the primary culprit. Numerous studies conducted in different countries support this notion. For example, a study in Japan revealed that 47.6% of T2DM patients experienced sleep disorders (PSQI of > 5), while a study in Pakistan reported a higher percentage of 57%.[1722]

In an endeavor to investigate the relationship between T2DM and sleep disorders, this research was carried out in Iran, situated in the MENA region. The study involved 163 individuals diagnosed with T2DM, comprising 101 (62%) men and 62 (38%) women, with an average age of 56.7 years. The evaluation involved the utilization of the PSQI questionnaire, which unveiled those 73 participants (44.8%) manifested indications of sleep disorders. This percentage notably surpassed the findings of a previous study conducted in the same country in 2012, which documented a 37% prevalence of sleep disorders.[23]

Breaking down the data further, it was observed that 58.2% of participants had good diabetes control (HbA1C < 7), and the occurrence of sleep disorders in this group was 28.4%. On the contrary, among those with poor diabetes control (HbA1C > 7), the occurrence of sleep disorders was higher at 55.8%. A comparison of these percentages revealed a risk ratio of 1.96, emphasizing the warning about the relationship between T2DM and its potential to induce sleep disorders.

A cross-sectional study with 1604 participants showed a robust correlation between sleep quality (PR = 1.40; 95%CI: 1.05–1.92) with T2DM.[2425] Thus, in our research, various variables, including subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, and daytime dysfunction, were thoroughly examined. Our study, consistent with numerous previous investigations in this field, revealed that uncontrolled diabetes has a significant impact on sleep quality (P < 0.005), sleep duration (P < 0.002), and daytime dysfunction (P < 0.01).[2425]

In addition, our research revealed a lack of a significant association between diabetes mellitus and sleep latency, contrary to findings in some other studies.[26] The observed mean BMI among our study participants, standing at 26.22 ± 1.95, is particularly noteworthy. This criterion alone has been shown to exert a substantial impact on the quality of sleep, a correlation substantiated by numerous studies conducted over an extended period.[27] While the overweight status can function as either a dependent or independent factor, it also holds the potential to act as a confounding variable, further emphasizing its multifaceted role in influencing sleep quality.

Conclusion

Overall, we can draw the conclusion that T2DM may exert a substantial influence on our sleep health and habits. This impact becomes particularly pronounced in patients who lack adequate care in managing their blood sugar levels.

Limitation

However, it is crucial to note that our study, given its limited participant pool, may not provide results that are entirely generalizable to the broader population on the flip side, it is essential to acknowledge that the data obtained in our study relied entirely on subjective assessments. This reliance on subjective reporting introduces a noteworthy element of bias that can significantly impact the robustness of our conclusions. The inherent subjectivity in the data collection process may lead to variations in individual interpretations, potentially influencing the accuracy and reliability of the findings.

In light of these limitations, the authors recommend conducting similar studies with larger participant samples. In addition to expanding the participant pool, employing comprehensive questionnaires and utilizing accurate and advanced facilities and equipment such as polysomnography for investigating the quality of patients’ sleep can yield more valuable and reliable data for future studies. This approach would contribute to a more nuanced understanding of the intricate relationship between T2DM and sleep health, allowing for more robust conclusions and practical implications.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Acknowledgment

We gratefully acknowledge all managers and staff in the Central Department of Education, and all managers of the Beheshti hospital in Hamadan Province that helped in the collection of all the data.
==== Refs
1 Khan MAB Hashim MJ King JK Govender RD Mustafa H Al Kaabi J Epidemiology of type 2 diabetes-global burden of disease and forecasted trends J Epidemiol Glob Health 2020 10 107 11 32175717
2 Jing Z Chu J Imam Syeda Z Zhang X Xu Q Sun L Zhou C Catastrophic health expenditure among type 2 diabetes mellitus patients: A province-wide study in Shandong, China J Diabetes Investig 2019 10 283 9
3 Sun H Saeedi P Karuranga S Pinkepank M Ogurtsova K Duncan BB IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 Diabetes Res Clin Pract 2022 183 109119 doi: 10.1016/j.diabres.2021.109119 34879977
4 Whiting DR Guariguata L Weil C Shaw J IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030 Diabetes Res Clin Pract 2011 94 311 21 22079683
5 Rahelić D Sedmo Izdanje Idf Dijabetes Atlasa--Poziv Na Trenutnu Akciju [7th edition of idf diabetes atlas--Call for immediate action Lijec Vjesn 2016 138 57 8 27290816
6 Jalilian H Heydari S Imani A Salimi M Mir N Najafipour F Economic burden of type 2 diabetes in Iran: A cost-of-illness study Health Sci Rep 2023 6 e1120 doi: 10.1002/hsr2.1120 36824619
7 Papatheodorou K Banach M Bekiari E Rizzo M Edmonds M Complications of diabetes 2017 J Diabetes Res 2018 2018 doi: 10.1155/2018/3086167
8 Hex N Bartlett C Wright D Taylor M Varley D Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs Diabet Med 2012 29 855 62 22537247
9 Tomic D Shaw JE Magliano DJ The burden and risks of emerging complications of diabetes mellitus Nat Rev Endocrinol 2022 18 525 39 35668219
10 Stettler C Allemann S Jüni P Cull CA Holman RR Egger M Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials Am Heart J 2006 152 27 38 16824829
11 Bitew ZW Alemu A Jember DA Tadesse E Getaneh FB Sied A Prevalence of glycemic control and factors associated with poor glycemic control: A systematic review and meta-analysis Inquiry 2023 60 469580231155716 doi: 10.1177/00469580231155716 36852627
12 Swanson LM Arnedt JT Rosekind MR Belenky G Balkin TJ Drake C Sleep disorders and work performance: Findings from the 2008 National Sleep Foundation Sleep in America poll J Sleep Res 2011 20 487 94 20887396
13 Chao CY Wu JS Yang YC Shih CC Wang RH Lu FH Sleep duration is a potential risk factor for newly diagnosed type 2 diabetes mellitus Metabolism 2011 60 799 804 20846701
14 Taheri S Lin L Austin D Young T Mignot E Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index PLoS Med 2004 1 e62 doi: 10.1371/journal.pmed.0010062 15602591
15 Leproult R Copinschi G Buxton O Van Cauter EJA Sleep loss results in an elevation of cortisol levels the next evening Sleep 1997 20 865 70 9415946
16 Buysse DJ Reynolds CF 3rd Monk TH Berman SR Kupfer DJ The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research Psychiatry Res 1989 28 193 213 2748771
17 Farooque R Herekar F Iftikhar S Patel MJ The frequency of poor sleep quality in patients with diabetes mellitus and its association with glycemic control Cureus 2020 12 e11608 doi: 10.7759/cureus.11608 33364126
18 Bailes BK Diabetes mellitus and its chronic complications AORN J 2002 76 265 82
19 Ogilvie RP Patel SR The epidemiology of sleep and diabetes Curr Diabetes Rep 2018 18 1 11
20 Reutrakul S Van Cauter E Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes Metabolism 2018 84 56 66 29510179
21 Antza C Kostopoulos G Mostafa S Nirantharakumar K Tahrani A The links between sleep duration, obesity and type 2 diabetes mellitus J Endocrinol 2022 252 125 41
22 Sakamoto R Yamakawa T Takahashi K Suzuki J Shinoda MM Sakamaki K Association of usual sleep quality and glycemic control in type 2 diabetes in Japanese: A cross sectional study. Sleep and Food Registry in Kanagawa (SOREKA) PloS One 2018 13 e0191771 29364963
23 Asghari A Kamrava SK Ghalehbaghi B Nojomi M Subjective sleep quality in urban population Arch Iran Med 2012 15 95 8 22292580
24 Fritschi C Redeker NS Contributions of comorbid diabetes to sleep characteristics, daytime symptoms, and physical function among patients with stable heart failure J Cardiovasc Nurs 2015 30 411 25078876
25 Ruiz-Burneo L Merino-Rivera JA Bernabé-Ortiz A Type 2 diabetes mellitus and sleep characteristics: A population-based study in Tumbes, Peru Rev Peru Med Exp Salud Pública 2022 39 55 64 35766740
26 Zhu B-Q Li XM Wang D Yu XF Sleep quality and its impact on glycaemic control in patients with type 2 diabetes mellitus Int J Nurs Sci 2014 1 260 5
27 Lee JH Cho J Sleep and obesity Sleep Med Clin 2022 17 111 6 35216758
